This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical features

Authoring team

Testosterone deficiency and unsuppressed follicle-stimulating and luteinizing hormones activity (directly or indirectly) is responsible for the most common phenotypic features seen in KS (1).

Characteristic clinical findings of a male with KS are as follows:

  • infertility (azoospermia or oligospermia)
    • in mosaic cases, reports of pregnancy without assisted medical technology has been reported
  • small, firm testes - in postpubertal patients the testicular volume is typically less than 10 ml
  • gynecomastia - incidence of gynecomastia in KS may vary between 56% to 88%
  • tall, slender body structure with long legs and shorter torso
  • features of persistent androgen deficiency -
    • loss of libido
    • reduced beard growth and secondary body hair
    • decreased muscle bulk and tone
    • decreased bone mineral density
    • susceptibility for thromboembolism
    • an increased risk of mortality from diabetic and cardiovascular complications
  • motor delay or dysfunction
  • speech and language difficulties
  • attention deficits
  • dyslexia or reading dysfunction
  • psychosocial or behavioral problems (2,3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.